HCW Biologics Stock Forecast

HCWB's stock price has decreased by -71.65% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for HCW Biologics stock has a target of 2.00, which predicts a -17.70% decrease from the current stock price of 2.43.

Price Target: $2.00 (-17.70%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$2.00	$2.00	$2.00
Change	-17.70%	-17.70%	-17.70%	-17.70%

* Price targets were last updated on May 29, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for HCW Biologics is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	3	3	3	3	3	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Okunewitch Maxim Group	Maxim Group	Strong Buy Maintains $120 → $35	Strong Buy	Maintains	$120 → $35	+1,340.33%	May 29, 2025
Tony Butler EF Hutton	EF Hutton	Strong Buy Initiates $360	Strong Buy	Initiates	$360	+14,714.81%	Jun 1, 2023
Constantine Davides EF Hutton	EF Hutton	Strong Buy Reiterates $360	Strong Buy	Reiterates	$360	+14,714.81%	Apr 19, 2023
Constantine Davides EF Hutton	EF Hutton	Strong Buy Reiterates $360	Strong Buy	Reiterates	$360	+14,714.81%	Mar 30, 2023
Constantine Davides EF Hutton	EF Hutton	Strong Buy Reiterates $360	Strong Buy	Reiterates	$360	+14,714.81%	Mar 23, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 54.23K

Revenue Next Year

n/a

EPS This Year

-0.98

from -10.63

EPS Next Year

-0.56

from -0.98

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	6.72M	2.84M	2.57M	54.23K	-	-
Revenue Growth	-	-	-57.73%	-9.68%	-97.89%	-	-
EPS	-27.41	-16.64	-27.83	-30.96	-10.63	-0.98	-0.56
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.01	-0.58
Avg	-0.98	-0.56
Low	-0.94	-0.54

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.